Clinical Trials
17 trialsNCT03258320 2026-01-12
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine
Phase 2/3 Recruiting
NCT00634647 2018-10-02
Satraplatin and Prednisone to Treat Prostate Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT01259479 2018-07-05
Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT00499694 2018-06-12
Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel
Barbara Ann Karmanos Cancer Institute
Phase NA Completed
NCT01289067 2018-02-13
Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT00473720 2013-01-23
Phase I Study of the Combination of Satraplatin and Abraxane in Advanced Cancers
Yale University
Phase 1 Completed
NCT00093132 2012-08-17
Satraplatin for Locally Advanced Non-Small Cell Lung Cancer With Simultaneous Radiotherapy
Agennix
Phase 1/2 Terminated
NCT00450970 2012-08-17
SPERA
Agennix
Phase 3 Terminated
NCT00069745 2012-08-07
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
Agennix
Phase 3 Completed
NCT00370383 2012-08-07
A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)
Agennix
Phase 2 Completed
NCT00313456 2012-05-10
A Phase I Study of the Oral Platinum Agent Satraplatin in Combination With Weekly Docetaxel
Agennix
Phase 1 Terminated
NCT00268970 2012-04-30
Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer
Agennix
Phase 2 Completed
NCT00265655 2012-03-28
Satraplatin for Patients With Metastatic Breast Cancer (MBC)
Agennix
Phase 2 Completed
NCT00125411 2012-03-26
Study of Satraplatin (JM-216) in Combination With Docetaxel
Agennix
Phase 1 Terminated
NCT00329329 2012-03-23
Study of Satraplatin With Capecitabine to Treat Advanced Solid Malignancies
Agennix
Phase 1 Terminated
NCT00480623 2012-03-23
A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence
Agennix
Phase 1 Terminated
NCT01220284 2010-10-13
Satraplatin and Vinorelbine in Advanced Solid Tumors
Southern Europe New Drug Organization
Phase 1 Unknown